IRadimed Corporation (IRMD)
IRMD Stock Price Chart
Explore IRadimed Corporation interactive price chart. Choose custom timeframes to analyze IRMD price movements and trends.
IRMD Company Profile
Discover essential business fundamentals and corporate details for IRadimed Corporation (IRMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Jul 2014
Employees
160.00
Website
https://www.iradimed.comCEO
Roger E. Susi
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
IRMD Financial Timeline
Browse a chronological timeline of IRadimed Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 30 Oct 2025
EPS estimate is $0.46, while revenue estimate is $20.50M.
Earnings released on 1 Aug 2025
EPS came in at $0.49 surpassing the estimated $0.45 by +8.89%, while revenue for the quarter reached $20.41M , missing expectations by -0.43%.
Dividend declared on 31 Jul 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 28 Aug 2025.
Earnings released on 5 May 2025
EPS came in at $0.42 falling short of the estimated $0.43 by -2.33%, while revenue for the quarter reached $19.51M , beating expectations by +0.92%.
Dividend declared on 5 May 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 30 May 2025.
Earnings released on 13 Feb 2025
EPS came in at $0.44 falling short of the estimated $0.45 by -2.22%, while revenue for the quarter reached $19.39M , beating expectations by +0.99%.
Dividend declared on 13 Feb 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 5 Mar 2025.
Earnings released on 31 Oct 2024
EPS came in at $0.43 surpassing the estimated $0.39 by +10.26%, while revenue for the quarter reached $18.33M , missing expectations by -3.24%.
Dividend declared on 31 Oct 2024
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 25 Nov 2024.
Earnings released on 1 Aug 2024
EPS came in at $0.42 surpassing the estimated $0.37 by +13.51%, while revenue for the quarter reached $17.93M , beating expectations by +1.58%.
Dividend declared on 31 Jul 2024
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 30 Aug 2024.
Earnings released on 2 May 2024
EPS came in at $0.36 surpassing the estimated $0.34 by +5.88%, while revenue for the quarter reached $17.60M , beating expectations by +2.73%.
Dividend declared on 2 May 2024
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 30 May 2024.
Earnings released on 8 Feb 2024
EPS came in at $0.39 falling short of the estimated $0.40 by -2.50%, while revenue for the quarter reached $17.45M , beating expectations by +0.70%.
Dividend declared on 12 Dec 2023
A dividend of $0.63 per share was announced, adjusted to $0.63. The dividend was paid on 12 Jan 2024.
Earnings released on 3 Nov 2023
EPS came in at $0.43 surpassing the estimated $0.36 by +19.44%, while revenue for the quarter reached $16.50M , beating expectations by +2.07%.
Earnings released on 3 Aug 2023
EPS came in at $0.36 surpassing the estimated $0.31 by +16.13%, while revenue for the quarter reached $16.13M , beating expectations by +3.07%.
Earnings released on 4 May 2023
EPS came in at $0.30 surpassing the estimated $0.28 by +7.14%, while revenue for the quarter reached $15.48M , beating expectations by +4.77%.
Earnings released on 2 Feb 2023
EPS came in at $0.32 surpassing the estimated $0.30 by +6.67%, while revenue for the quarter reached $14.86M , missing expectations by -0.24%.
Dividend declared on 1 Feb 2023
A dividend of $1.05 per share was announced, adjusted to $1.05. The dividend was paid on 21 Feb 2023.
Earnings released on 3 Nov 2022
EPS came in at $0.29 surpassing the estimated $0.25 by +16.00%, while revenue for the quarter reached $13.41M , beating expectations by +1.67%.
Earnings released on 29 Jul 2022
EPS came in at $0.26 surpassing the estimated $0.24 by +8.33%, while revenue for the quarter reached $12.72M , beating expectations by +0.96%.
Earnings released on 29 Apr 2022
EPS came in at $0.22 surpassing the estimated $0.21 by +4.76%, while revenue for the quarter reached $12.31M , beating expectations by +0.81%.
Dividend declared on 7 Feb 2022
A dividend of $1.00 per share was announced, adjusted to $1.00. The dividend was paid on 24 Feb 2022.
Earnings released on 4 Feb 2022
EPS came in at $0.33 surpassing the estimated $0.21 by +57.14%, while revenue for the quarter reached $11.87M , beating expectations by +1.91%.
Earnings released on 29 Oct 2021
EPS came in at $0.23 surpassing the estimated $0.17 by +35.29%, while revenue for the quarter reached $10.91M , beating expectations by +4.88%.
Earnings released on 30 Jul 2021
EPS came in at $0.14 surpassing the estimated $0.10 by +40.00%, while revenue for the quarter reached $9.81M , beating expectations by 0.00%.
Earnings released on 30 Apr 2021
EPS came in at $0.13 surpassing the estimated $0.10 by +30.00%, while revenue for the quarter reached $9.22M , beating expectations by +42.86%.
Earnings released on 4 Feb 2021
EPS came in at $0.07 falling short of the estimated $0.09 by -22.22%, while revenue for the quarter reached $8.55M , missing expectations by -26.67%.
Earnings released on 30 Oct 2020
EPS came in at $0.11 surpassing the estimated $0.10 by +10.00%, while revenue for the quarter reached $7.70M , beating expectations by +10.00%.
IRMD Stock Performance
Access detailed IRMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.